Moesin Serves as Scaffold Protein for PD-L1 in Human Uterine Cervical Squamous Carcinoma Cells

Immune checkpoint blockade (ICB) therapy targeting the programmed death ligand-1 (PD-L1)/PD-1 axis has emerged as a promising treatment for uterine cervical cancer; however, only a small subset of patients with uterine cervical squamous cell carcinoma (SCC) derives clinical benefit from ICB therapie...

Descripción completa

Detalles Bibliográficos
Autores principales: Doukuni, Rina, Kobori, Takuro, Tanaka, Chihiro, Tameishi, Mayuka, Urashima, Yoko, Ito, Takuya, Obata, Tokio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267616/
https://www.ncbi.nlm.nih.gov/pubmed/35807113
http://dx.doi.org/10.3390/jcm11133830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267616/
https://www.ncbi.nlm.nih.gov/pubmed/35807113
http://dx.doi.org/10.3390/jcm11133830

Ejemplares similares